Recorded presentation

Joel Lexchin, MD, School of Health Policy and Management, York University, 121 Walmer Rd., Toronto, ON M5R 2X8, Canada, 416-964-7186, joel.lexchin@utoronto.ca

Canada maintains lower prices for prescription drugs than the U.S. drugs are available and accessible to Canadians, and health and health care are not adversely affected. This presentation analyzes how it is posible to keep drug prices at an affordable level, while supporting research and development. Drug prices can be reduced in the U.S. without destroying pharmaceutical research and development.

Learning Objectives: At the conclusion of the session, the participant in the session will

• recognize the factors that have led to lower drug prices in Canada and the impact of this on health services.
• understand how drug prices can be lowered without hurting health care or adversely affecting pharmaceutical R&D in the U.S.

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

Recorded presentation